Human milk components modulate toll-like receptor-mediated inflammation

Advances in Nutrition

Volumn 7, Issue 1, 2016, Pages 102-111

  He, YingYing ^a   Lawlor, Nathan T ^a,b   Newburg, David S ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Glycans; Human milk; Immune function; Inflammation; Toll like receptors

Indexed keywords

AUTACOID; TOLL LIKE RECEPTOR;

BREAST FEEDING; BREAST MILK; CHEMISTRY; DIET THERAPY; ENTEROCOLITIS, NECROTIZING; HUMAN; INFLAMMATION; METABOLISM; NEWBORN; SEPSIS;

BREAST FEEDING; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFLAMMATION; INFLAMMATION MEDIATORS; MILK, HUMAN; SEPSIS; TOLL-LIKE RECEPTORS;

EID: 85000443028     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.115.010090     Document Type: Review

References (121)

1. Newburg DS. Glycobiology of human milk. Biochemistry 2013;78:771-85
2. Ballard O, Morrow AL. Human milk composition: Nutrients and bioactive factors. Pediatr Clin North Am 2013;60:49-74
3. He Y, Liu S, Kling DE, Leone S, Lawlor NT, Huang Y, Feinberg SB, HillDR, Newburg DS. The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuatingLPS-induced inflammation. Gut 2014;gutjnl-2014
4. Newburg DS, Grave G. Recent advances in human milk glycobiology.Pediatr Res 2014;75:675-9
5. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, NewburgDS. Campylobacter jejuni binds intestinal H(O) antigen (Fucalpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003;278:14112-20
6. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25:37-58
7. Liu B, Newburg DS. Human milk glycoproteins protect infants against human pathogens. Breast feed Med 2013;8:354-62
8. Newburg DS, Morelli L. Human milk and infant intestinal mucosalglycans guide succession of the neonatal intestinal microbiota. PediatrRes 2015;77:115-20
9. Bode L,McGuire M, Rodriguez JM, Geddes DT, Hassiotou F, HartmannPE, McGuire MK. It's alive:Microbes and cells in human milk and their potential benefits to mother and infant. Adv Nutr 2014;5:571-3
10. Hunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z, FoxLK, Williams JE, McGuire MK, McGuire MA. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 2011;6:e21313
11. Sela DA, Mills DA. Nursing our microbiota: molecular linkages between bifido bacteria and milk oligosaccharides. Trends Microbiol2010;18:298-307
12. Yu ZT, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, Heidtman M, Newburg DS. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology2013;23:169-77
13. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012;489:231-41
14. Cebra JJ. Influences of microbiota on intestinal immune system development.Am J Clin Nutr 1999;69:1046S-51S
15. Nanthakumar NN, Dai D, Newburg DS, Walker WA. The role of indigenous microflora in the development of murine intestinal fucosylandsialyl transferases. FASEB J 2003;17:44-6
16. Shen Q, Tuohy KM, Gibson GR, Ward RE. In vitro measurement of the impact of human milk oligosaccharides on the faecal microbiota of weaned formula-fed infants compared to a mixture of prebiotic fructooli gosaccharides and galactooligosaccharides. Lett Appl Microbiol2011;52:337-43
17. Weiss GA, Chassard C, Hennet T. Selective proliferation of intestinal Barnesiella under fucosyllactose supplementation in mice. Br J Nutr2014;111:1602-10
18. Rinne M, Kalliomaki M, Arvilommi H, Salminen S, Isolauri E. Effect of probiotics and breast feeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr2005;147:186-91
19. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu L, Uauy R,Llanos A, Claud EC, Walker WA. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innateimmune response. PLoS One 2011;6:e17776
20. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379-90
21. Kuo S, El Guindy A, Panwala CM, Hagan PM, Camerini V. Differential appearance of T cell subsets in the large and small intestine of neonatalmice. Pediatr Res 2001;49:543-51
22. Abrahamsson TR, Sandberg Abelius M, Forsberg A, Bjorksten B,Jenmalm MCA. Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. ClinExp Allergy 2011;41:1729-39
23. Thomas JE, Austin S, Dale A, McClean P, Harding M, Coward WA,Weaver LT. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993;342:121
24. Garofalo R. Cytokines in human milk. J Pediatr 2010;156:S36-40
25. Kverka M, Burianova J, Lodinova-Zadnikova R, Kocourkova I, Cinova J, Tuckova L, Tlaskalova-Hogenova H. Cytokine profiling in human colostrum and milk by protein array. Clin Chem 2007;53:955-62
26. Speer CP, Schatz R, Gahr M. [Function of breast milk macrophages. Monatsschr Kinderheilkd 1985;133:913-7
27. Ichikawa M, Sugita M, Takahashi M, Satomi M, Takeshita T, Araki T,Takahashi H. Breast milk macrophages spontaneously producegranulocyte-macrophage colony-stimulating factor and differentiate intodendritic cells in the presence of exogenous interleukin-4 alone. Immunology2003;108:189-95
28. Buescher ES. Anti-inflammatory characteristics of human milk: How,where, why. Adv Exp Med Biol 2001;501:207-22
29. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol2004;4:499-511
30. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol2001;1:135-45
31. Serino L, Virji M. Phosphorylcholine decoration of lipopolysaccharide differentiates commensal Neisseriae from pathogenic strains: Identification of licA-type genes in commensal Neisseriae. Mol Microbiol2000;35:1550-9
32. Lebeer S, Vanderleyden J, De Keersmaecker SC. Host interactions ofprobiotic bacterial surface molecules: Comparison with commensals and pathogens. Nat Rev Microbiol 2010;8:171-84
33. Cario E, Podolsky DK. Intestinal epithelial TOLLerance versus in-TOLLerance of commensals. Mol Immunol 2005;42:887-93
34. Bordon Y. Mucosal immunology: TLRs get rhythm. Nat Rev Immunol2013;13:392
35. Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinalepithelium is orchestrated by the circadian clock and microbiotacues transduced by TLRs. Cell 2013;153:812-27
36. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is requiredfor intestinal homeostasis. Cell 2004;118:229-41
37. Nanthakumar NN, Meng D, Newburg DS. Glucocorticoids and microbiotaregulate ontogeny of intestinal fucosyltransferase 2 requisitefor gut homeostasis. Glycobiology 2013;23:1131-41
38. Neal MD, Sodhi CP, Jia H, Dyer M, Egan CE, Yazji I, Good M, Afrazi A,Marino R, Slagle D, et al. Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 upregulated modulator of apoptosis. J Biol Chem 2012;287:37296-308
39. Santaolalla R, Sussman DA, Ruiz JR, Davies JM, Pastorini C, EspanaCL, et al. TLR4 activates the beta-catenin pathway to cause intestinal neoplasia. PLoS One 2013;8:e63298
40. Gersemann M, Wehkamp J, Stange EF. Innate immune dysfunction in inflammatory bowel disease. J Intern Med 2012;271:421-8
41. Cario E. Toll-like receptors in inflammatory bowel diseases: A decade later. Inflamm Bowel Dis 2010;16:1583-97
42. Hennessy EJ, Parker AE, O'Neill LA. Targeting Toll-like receptors:Emerging the rapeutics? Nat Rev Drug Discov 2010;9:293-307
43. Glaser K, Speer CP. Toll-like receptor signaling in neonatal sepsis and inflammation: A matter of orchestration and conditioning. Expert RevClin Immunol 2013;9:1239-52
44. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, Griffin GE, Ferrara P, Schiffrin EJ, Morgan BP, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003;171:6680-9
45. Langjahr P, Díaz-Jiménez D, De la Fuente M, Rubio E, Golenbock D,Bronfman FC, et al. Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) Production.PLoS One 2014;9:e104624
46. Labéta MO, Vidal K, Nores JE, Arias M, Vita N, Morgan BP,Guillemot JC, Loyaux D, Ferrara P, Schmid D, et al. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med2000;191:1807-12
47. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP onLPS-host cell interactions. J Endotoxin Res 2005;11:225-9
48. Zunt SL, Burton LV, Goldblatt LI, Dobbins EE, Srinivasan M. Solubleforms of toll-like receptor 4 are present in human saliva and modulate tumour necrosis factor-alpha secretion by macrophage-like cells. ClinExp Immunol 2009;156:285-93
49. Adlerova L, Bartskova A, Raldyna M. Lactoferrin: A review. Vet Med(Praha) 2008;9:457-65
50. Tsukada H, Fukui A, Tsujita T, Matsumoto M, Iida T, Seya T. Fish solubletoll-like receptor 5 (TLR5S) is an acute-phase protein with integral flagellin-recognition activity. Int J Mol Med 2005;15:519-25
51. Kusunoki R, Ishihara S, Aziz M, Oka A, Tada Y, Kinoshita Y. Roles of milk fat globule-epidermal growth factor 8 in intestinal inflammation.Digestion 2012;85:103-7
52. Chogle A, Bu HF, Wang X, Brown JB, Chou PM, Tan XD. Milk fatglobule-EGF factor 8 is a critical protein for healing of dextran sodiumsulfate-induced acute colitis in mice. Mol Med 2011;17:502-7
53. Aziz M, Jacob A, Matsuda A, Wang P. Review: Milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation. Apoptosis 2011;16:1077-86
54. Ando K, Hasegawa K, Shindo K, Furusawa T, Fujino T, Kikugawa K,Nakano H, Takeuchi O, Akira S, Akiyama T, et al. Human lacto ferrinactivates NF-kappaB through the toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling.FEBS J 2010;277:2051-66
55. Legrand D, Elass E, Carpentier M, Mazurier J. Lactoferrin: A modulatorof immune and inflammatory responses. Cell Mol Life Sci2005;62:2549-59
56. LeBouder E, Rey-Nores JE, Raby AC, Affolter M, Vidal K, ThorntonCA, Labéta MO. Modulation of neonatal microbial recognition:TLR-mediated innate immune responses are specifically and differentially modulated by human milk. J Immunol 2006;176:3742-52
57. Stroinigg N, Srivastava MD. Modulation of toll-like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defensin-2. Allergy Asthma Proc 2005;26:299-309
58. Chen AC, Chung MY, Chang JH, Lin HC. Pathogenesis implicationfor necrotizing enterocolitis prevention in preterm very-low-birth weight infants. J Pediatr Gastroenterol Nutr 2014;58:7-11
59. Thomas PG, Carter MR, Atochina O, Da'Dara AA, Piskorska D,McGuire E, Harn DA. Maturation of dendritic cell 2 phenotype bya helminth glycan uses a toll-like receptor 4-dependent mechanism.J Immunol 2003;171:5837-41
60. Kurakevich E, Hennet T, Hausmann M, Rogler G, Borsig L. Milk oligosaccharidesialyl(alpha2,3)lactose activates intestinal CD11c+ cells through TLR4. Proc Natl Acad Sci USA 2013;110:17444-9
61. Jantscher-Krenn E, Zherebtsov M, Nissan C, Goth K, Guner YS,Naidu N, Choudhury B, Grishin AV, Ford HR, Bode L. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitisin neonatal rats. Gut 2012;61:1417-25
62. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998;395:284-8
63. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ.Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-9
64. Hashimoto M, Tawaratsumida K, Kariya H, Aoyama K, Tamura T,Suda Y. Lipoprotein is a predominant toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 2006;18:355-62
65. Tapping RI, Tobias PS. Mycobacterial lipoarabinomannan mediatesphysical interactions between TLR1 and TLR2 to induce signaling.J Endotoxin Res 2003;9:264-8
66. Sato M, Sano H, Iwaki D, Kudo K, Konishi M, Takahashi H, Takahashi T, Imaizumi H, Asai Y, Kuroki Y. Direct binding of toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol 2003;171:417-25
67. Le Mandat Schultz A, Bonnard A, Barreau F, Aigrain Y, Pierre-Louis C, Berrebi D, Peuchmaur M. Expression of TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of necrotizing enterocolitis.PLoS One 2007;2:e1102
68. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, Tatevian N, Rhoads JM.Changes in intestinal toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009;297:G442-50
69. Raby AC, Le Bouder E, Colmont C, Davies J, Richards P, Coles B,George CH, Jones SA, Brennan P, Topley N, et al. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol 2009;183:506-17
70. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway.Cytokine 2008;42:145-51
71. Beutler B, Rietschel ET. Innate immune sensing and its roots: Thestory of endotoxin. Nat Rev Immunol 2003;3:169-76
72. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, DubowskiTD, Sodhi CP, Hackam DJ. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair.J Immunol 2007;179:4808-20
73. Newburg DS, Peterson JA, Ruiz-Palacios GM, Matson DO, MorrowAL, Shults J, Guerrero ML, Chaturvedi P, Newburg SO, Scallan CD,et al. Role of human-milk lactadherin in protection against symptomaticrota virus infection. Lancet 1998;351:1160-4
74. Garcia C, Duan RD, Brevaut-Malaty V, Gire C, Millet V, Simeoni U,Bernard M, Armand M. Bioactive compounds in human milk and intestinal health and maturity in preterm newborn: An overview. CellMol Biol 2013;59:108-31
75. Zhou YJ, Gao J, Yang HM, Yuan XL, Chen TX, He ZJ. The role of thelactadherin in promoting intestinal DCs development in vivo and vitro.Clin Dev Immunol 2010;2010:357541
76. Queiroz VA, Assis AM and R Júnior Hda C. Protective effect of human lactoferrin in the gastro intestinal tract. Rev Paul Pediatr 2013;31:90-5
77. Brock JH. Lactoferrin in human milk: Its role in iron absorption and protection against enteric infection in the newborn infant. Arch DisChild 1980;55:417-21
78. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res 2007;61:2-8
79. Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin:Sensitivity of a variety of micro organisms. Infect Immun1980;28:893-8
80. Petschow BW, Talbott RD, Batema RP. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent ofreceptor binding capacity and iron saturation level. J Med Microbiol1999;48:541-9
81. Håversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol2002;220:83-95
82. Venkatesh MP, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2010;5:CD007137
83. Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2015;2:CD007137
84. Baricelli J, Rocafull MA, Vazquez D, Bastidas B, Baez-Ramirez E,Thomas LE. β-defensin-2 in breast milk displays a broad antimicrobial activity against pathogenic bacteria. J Pediatr (Rio J) 2015;91:36-43
85. Hill DR, Rho HK, Kessler SP, Amin R, Homer CR, McDonald C,Cowman MK, de la Motte CA. Human milk hyaluronan enhances innatedefense of the intestinal epithelium. J Biol Chem 2013;288:29090-104
86. Jenke AC, Zilbauer M, Postberg J,Wirth S. Human beta-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis. PediatrRes 2012;72:513-20
87. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single stranded RNA. Science 2004;303:1529-31
88. Chichlowski M, German JB, Lebrilla CB, Mills DA. The influence of milk oligosaccharides on microbiota of infants: Opportunities for formulas.Annu Rev Food Sci Technol 2011;2:331-51
89. Schumacher G, Bendas G, Stahl B, Beermann C. Human milk oligosaccharides affect P-selectin binding capacities: In vitro investigation.Nutrition 2006;22:620-7
90. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S.Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelialcells by human milk oligosaccharides. Thromb Haemost2004;92:1402-10
91. Vos AP, M'Rabet L, Stahl B, Boehm G, Garssen J. Immune-modulatory effects and potential working mechanisms of orally applied non digestible carbohydrates. Crit Rev Immunol 2007;27:97-140
92. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin10 production by B220+ cells from schistosome-infected mice: Amechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad SciUSA 1994;91:18-22
93. Terrazas LI, Walsh KL, Piskorska D, McGuire E, Harn DA, Jr. Theschistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cellsthat secrete anti-inflammatory cytokines and inhibit proliferation ofnaive CD4(+) cells: a potential mechanism for immune polarizationin helminth infections. J Immunol 2001;167:5294-303
94. Eiwegger T, Stahl B, Haidl P, Schmitt J, Boehm G, Dehlink E, Urbanek R, Szépfalusi Z. Prebiotic oligosaccharides: In vitro evidence for gastro intestinal epithelial transfer and immuno modulatory properties.Pediatr Allergy Immunol 2010;21:1179-88
95. Lane JA, O'Callaghan J, Carrington SD, Hickey RM. Transcriptional response of HT-29 intestinal epithelial cells to human and bovine milk oligosaccharides. Br J Nutr 2013;110:2127-37
96. Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, Pollakis G, Paxton WA. Lewis X component in human milk bindsDC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005;115:3256-64
97. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C,et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009;44:1072-5
98. Breast feeding and the use of human milk. Pediatrics 2012;129:e827-41
99. Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawöger R, Kiechl-Kohlendorfer U, Chan GM, Blanco CL, Abrams S, Cotten CM. An exclusively human milk-based diet is associated with a lower rate of necrotizingenterocolitis than a diet of human milk and bovine milk-based products.J Pediatr 2010;156:562-7.e1
100. Meinzen-Derr J, Poindexter B,Wrage L, Morrow AL, Stoll B, DonovanEF. Role of human milk in extremely low birth weight infants' risk ofnecrotizing enterocolitis or death. J Perinatol 2009;29:57-62
101. McGuire W, Anthony MY. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review.Arch Dis Child Fetal Neonatal Ed 2003;88:F11-4
102. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammationin the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad SciUSA 2000;97:6043-8
103. Sodhi CP, Neal MD, Siggers R, Sho S, Ma C, Branca MF, Prindle T Jr,Russo AM, Afrazi A, Good M, et al. Intestinal epithelial Toll-like receptor4 regulates goblet cell development and is required for necrotizingenterocolitis in mice. Gastroenterology 2012;143:708-18e1-5
104. Gribar SC, Sodhi CP, Richardson WM, Anand RJ, Gittes GK, BrancaMF, Jakub A, Shi XH, Shah S, Ozolek JA. Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizingenterocolitis. J Immunol 2009;182:636-46
105. Caplan MS, Simon D, Jilling T. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin PediatrSurg 2005;14:145-51
106. Hackam DJ, Afrazi A, Good M, Sodhi CP. Innate immune signaling in the pathogenesis of necrotizing enterocolitis. Clin Dev Immunol 2013;2013:475415
107. Soliman A, Michelsen KS, Karahashi H, Lu J, Meng FJ, Qu X, CrotherTR, Rabizadeh S, Chen S, Caplan MS. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: Implication for the pathogenesis of necrotizing enterocolitis. PLoS One 2010;5:E15044
108. Chan KL, Wong KF, Luk JM. Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications. World J Gastroenterol 2009;15:4745-52
109. Jilling T, Simon D, Lu J, Meng FJ, Li D, Schy R, Thomson RB, Soliman A, Arditi M, Caplan MS. The roles of bacteria and TLR4 in rat andmurine models of necrotizing enterocolitis. J Immunol 2006;177:3273-82
110. Afrazi A, Sodhi CP, Richardson W, Neal M, Good M, Siggers R,Hackam DJ. New insights into the pathogenesis and treatment of necrotizingenterocolitis: Toll-like receptors and beyond. Pediatr Res2011;69:183-8
111. Sherman MP. Lactoferrin and necrotizing enterocolitis. Clin Perinatol2013;40:79-91
112. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B,Daily P, Apostol M, Petit S, Farley M, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011;30:937-41
113. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC,et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010;126:443-56
114. Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van MeursKP, Bizzarro MJ, Goldberg RN, Frantz ID III, Hale EC, et al. Early onsetneonatal sepsis: The burden of group B Streptococcal and E. colidisease continues. Pediatrics 2011;127:817-26
115. Abu-Maziad A, Schaa K, Bell EF, Dagle JM, Cooper M, Marazita ML,et al. Role of polymorphic variants as genetic modulators of infection in neonatal sepsis. Pediatr Res 2010;68:323-9
116. Graham, 3rd PL, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L.Risk factors for late onset gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr InfectDis J 2006;25:113-7
117. Viemann D, Dubbel G, Schleifenbaum S, Harms E, Sorg C, Roth J. Expression of toll-like receptors in neonatal sepsis. Pediatr Res 2005;58:654-9
118. Williams DL, Ha T, Li C, Kalbfleisch JH, Schweitzer J, Vogt W,Browder IW. Modulation of tissue toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality.Crit Care Med 2003;31:1808-18
119. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL,Mauri D, et al. Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA 2009;106:2348-52
120. Ashraf RN, Jalil F, Zaman S, Karlberg J, Khan SR, Lindblad BS,Hanson LA. Breast feeding and protection against neonatal sepsis ina high risk population. Arch Dis Child 1991;66:488-90
121. Kaur G, Gathwala G. Efficacy of bovine lactoferrin supplementation inpreventing late-onset sepsis in low birth weight neonates: A randomized placebo-controlled clinical trial. J Trop Pediatr 2015;61:370-6.